BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23474519)

  • 1. Dabigatran overdose secondary to acute kidney injury and amiodarone use.
    Fountzilas C; George J; Levine R
    N Z Med J; 2013 Mar; 126(1370):110-2. PubMed ID: 23474519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal bleeding under dabigatran.
    Stöllberger C; Lindner K; Finsterer J
    J Postgrad Med; 2014; 60(2):192-3. PubMed ID: 24823522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Patient with acute renal injury presenting dabigatran overdose: Hemodialysis for surgery].
    Bachellerie B; Ruiz S; Conil JM; Crognier L; Seguin T; Georges B; Fourcade O
    Ann Fr Anesth Reanim; 2014 Jan; 33(1):44-6. PubMed ID: 24378048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct thrombin inhibitors: a case indicating benefit from 'plasmapheresis' in toxicity: a call for establishing "guidelines" in overdose and to find an "antidote"!
    Kamboj J; Kottalgi M; Cirra VR; Shah N; Kamboj R
    Am J Ther; 2012 Nov; 19(6):e182-5. PubMed ID: 23154229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma dabigatran activity one week after discontinuation despite normal renal function.
    Thachil J; Pike G; Keighley-Jones L; Nash MJ
    Am J Med; 2013 Aug; 126(8):e5-6. PubMed ID: 23800582
    [No Abstract]   [Full Text] [Related]  

  • 6. Dabigatran-induced acute hepatitis.
    Rochwerg B; Xenodemetropoulos T; Crowther M; Spyropoulos A
    Clin Appl Thromb Hemost; 2012 Sep; 18(5):549-50. PubMed ID: 22962308
    [No Abstract]   [Full Text] [Related]  

  • 7. Dabigatran in patients with nonvalvular atrial fibrillation.
    Gage L
    J Am Coll Cardiol; 2011 Jul; 58(5):551; author reply 551. PubMed ID: 21777759
    [No Abstract]   [Full Text] [Related]  

  • 8. Relation between dabigatran concentration, as assessed using the direct thrombin inhibitor assay, and activated clotting time/activated partial thromboplastin time in patients with atrial fibrillation.
    Okubo K; Kuwahara T; Takagi K; Takigawa M; Nakajima J; Watari Y; Nakashima E; Yamao K; Fujino T; Tsutsui H; Takahashi A
    Am J Cardiol; 2015 Jun; 115(12):1696-9. PubMed ID: 25918026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective elimination of dabigatran by haemodialysis. A phase I single-centre study in patients with end-stage renal disease.
    Khadzhynov D; Wagner F; Formella S; Wiegert E; Moschetti V; Slowinski T; Neumayer HH; Liesenfeld KH; Lehr T; Härtter S; Friedman J; Peters H; Clemens A
    Thromb Haemost; 2013 Apr; 109(4):596-605. PubMed ID: 23389759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dabigatran for stroke prevention in atrial fibrillation.
    Hohnloser SH; Diener HC
    Hamostaseologie; 2012; 32(3):216-20. PubMed ID: 22739760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous gross haematuria during dabigatran therapy for secondary stroke prevention.
    Stöllberger C; Rakusan S; Wimpissinger FT; Finsterer J
    Thromb Haemost; 2012 Sep; 108(3):579-81. PubMed ID: 22739630
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anticoagulant therapy in connection with cardioversion in patients with atrial fibrillation].
    Furman NV; Kuvshinova LE; Dovgalevskiĭ IaP
    Kardiologiia; 2012; 52(9):69-76. PubMed ID: 23098549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removal of dabigatran by hemodialysis.
    Chang DN; Dager WE; Chin AI
    Am J Kidney Dis; 2013 Mar; 61(3):487-9. PubMed ID: 23219111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dabigatran-induced gastrointestinal bleeding in an elderly patient with moderate renal impairment.
    Wychowski MK; Kouides PA
    Ann Pharmacother; 2012 Apr; 46(4):e10. PubMed ID: 22496474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating and assessing dabigatran drug interactions.
    Nguyen T; Wong E
    Consult Pharm; 2012 Jul; 27(7):509-12. PubMed ID: 22910132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dabigatran: an oral direct thrombin inhibitor for use in atrial fibrillation.
    Bendel SD; Bona R; Baker WL
    Adv Ther; 2011 Jun; 28(6):460-72. PubMed ID: 21533567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agranulocytosis immediately after oral administration of cibenzoline and dabigatran in a patient with paroxysmal atrial fibrillation.
    Hayashi H; Kitoh K; Mitsunami K; Horie M
    Intern Med; 2012; 51(15):1987-90. PubMed ID: 22864123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of dabigatran-associated acute renal failure.
    Shafi ST; Negrete H; Roy P; Julius CJ; Sarac E
    WMJ; 2013 Aug; 112(4):173-5; quiz 176. PubMed ID: 24734407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemic stroke in an obese patient receiving dabigatran.
    Breuer L; Ringwald J; Schwab S; Köhrmann M
    N Engl J Med; 2013 Jun; 368(25):2440-2. PubMed ID: 23782198
    [No Abstract]   [Full Text] [Related]  

  • 20. Impaired renal function and bleeding in elderly treated with dabigatran.
    Berthelot E; Lavenu-Bombled C; Orostegui-Giron L; Desconclois C; Assayag P
    Blood Coagul Fibrinolysis; 2014 Sep; 25(6):618-20. PubMed ID: 24509332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.